Insider trade

Officer sold ~$1.04M of CRL shares in the open market

Traded Aug 11, 2026 · Filed Aug 13, 2026

~$1.04M
Reported value · 3,714 sh @ $279.66: 4,807
Holds after · shares reported: +1.7%
stock since the trade · S&P 500 -0.8%, $282.00 → $286.83 on Oct 1

Why it stands out

Charles River Laboratories's CEVP, Disc & Safety Assessment sold $1.04M of Charles River Laboratories shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 11, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 13, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,038,657

Shares × reported transaction price

Timing vs results

6 days after results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $282.00 on Aug 11, 2026, at its 52-week high, after a 25% rise over the previous 30 trading days

52-week range $145.57 (Sep 25, 2025) to $282.00 (Aug 11, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $225.57 on Jun 29, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred